CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

Clinerion Expands RWD Platform to Offer Unique Healthcare Insights Using EHR Data

Clinerion Expands RWD Platform to...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

Clinerion Expands RWD Platform to Offer Unique Healthcare Insights Using EHR Data

Clinerion Expands RWD Platform to...

The Growing Demand for Contract Research Organizations

Life Sciences Review | Wednesday, June 30, 2021
Tweet

Industry players are investing more in infectious disease research and development, employing bioinformatics and other analytical technologies to respond to bacterial and viral infections effectively.


FREMONT, CA: As a result of the growing benefits of clinical trials in emerging countries, the global Contract Research Organization (CRO) market is expected to increase in the coming years. Similarly, the government's strong emphasis on public healthcare reform in emerging nations, combined with their high purchasing power, will drive greater demand for CRO services in the future years.


To achieve a competitive advantage and maintain flexibility, pharmaceutical corporations outsource research efforts to numerous university institutes and private CROs. Furthermore, they are placing a strong emphasis on creating novel drugs to treat a variety of chronic conditions. In the following years, the variables above will broaden the scope of CRO market trends. According to a study, the worldwide CRO industry is estimated to reach 61 billion dollars by 2025.


Growing Demand for Effective Medications to Treat Chronic Conditions


Clinical research and life sciences have seen significant investment in the global market. This reason, combined with the rising demand for clinical trials and quality auditing worldwide, will drive up the demand for various types of contract research businesses in the coming years. Furthermore, increased investments in research and development, combined with rapid advancements in the IT (Information Technology) sector, will result in significant advances in clinical trials, which will positively impact the CRO market outlook shortly.


Rising Prevalence of Infectious Diseases Such as Influenza


Because of the rising prevalence of meningitis, influenza, tuberculosis, and other infectious diseases, the global CRO market from the infectious disease category is expected to rise at about 6.5 percent by 2025. In addition, industry players are investing more in infectious disease research and development, employing bioinformatics and other analytical technologies to respond to bacterial and viral infections effectively. In the years ahead, a growing contract research organization list aimed at rapid developments in Hepatitis C virus clinical research will promote drug discovery and, as a result, boost overall industry dynamics.


See Also: Top Biomechanics Solution Companies


Weekly Brief

loading
Top 10 CROs - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-growing-demand-for-contract-research-organizations-nwid-431.html